Components	No. of subjects having the specific component at enrolment	No. of subjects having changes in the specific component after methylprednisolone				*p
Components	No. of subjects having the specific component at enrolment	Status	1st visit n	2nd visit n	3rd visit n (%)	*p
Lid retraction/lid lag	30	Improved	1	6	21 (70)	<0.001
Lid retraction/lid lag	30	Not improved	29	23	9 (30)	<0.001
Soft tissue involvement	30	Improved	30	30	30 (100)	<0.001
Soft tissue involvement	30	Not improved	0	0	0 (0)	<0.001
Bilateral proptosis	19	Improved	4	3	12 (63.2)	<0.001
Bilateral proptosis	19	Not improved	15	12	7 (36.8)	<0.001
Right eye proptosis	9	Improved	2	2	5 (55.6)	<0.05
Right eye proptosis	9	Not improved	7	5	4 (44.4)	<0.05
Left eye proptosis	2	Improved	0	0	1 (50)	>0.05
Left eye proptosis	2	Not improved	2	2	1 (50)	>0.05
EOM involvement (Diplopia)	15	Improved	8	3	13 (86.7)	<0.001
EOM involvement (Diplopia)	15	Not improved	7	4	2 (13.3)	<0.001
Clinical activity score	30	5 (median)			2 (median)	<0.001